294 related articles for article (PubMed ID: 21586613)
21. Fyn requires HnRNPA2B1 and Sam68 to synergistically regulate apoptosis in pancreatic cancer.
Chen ZY; Cai L; Zhu J; Chen M; Chen J; Li ZH; Liu XD; Wang SG; Bie P; Jiang P; Dong JH; Li XW
Carcinogenesis; 2011 Oct; 32(10):1419-26. PubMed ID: 21642356
[TBL] [Abstract][Full Text] [Related]
22. Downstream targets of heterogeneous nuclear ribonucleoprotein A2 mediate cell proliferation.
He Y; Rothnagel JA; Epis MR; Leedman PJ; Smith R
Mol Carcinog; 2009 Feb; 48(2):167-79. PubMed ID: 18680105
[TBL] [Abstract][Full Text] [Related]
23. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.
Loh TJ; Moon H; Cho S; Jang H; Liu YC; Tai H; Jung DW; Williams DR; Kim HR; Shin MG; Liao DJ; Zhou J; Shi W; Zheng X; Shen H
Oncol Rep; 2015 Sep; 34(3):1231-8. PubMed ID: 26151392
[TBL] [Abstract][Full Text] [Related]
24. Oral squamous cancer cell exploits hnRNP A1 to regulate cell cycle and proliferation.
Yu C; Guo J; Liu Y; Jia J; Jia R; Fan M
J Cell Physiol; 2015 Sep; 230(9):2252-61. PubMed ID: 25752295
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer.
Zhou J; Allred DC; Avis I; Martínez A; Vos MD; Smith L; Treston AM; Mulshine JL
Breast Cancer Res Treat; 2001 Apr; 66(3):217-24. PubMed ID: 11510693
[TBL] [Abstract][Full Text] [Related]
26. [Role of heterogeneous nuclear ribonucleoprotein A2/B1 protein in the pathogenesis of non-small cell lung cancer].
Shi Y; Chen Y; Hou YY; Ji CH; Hu Q; Zhou Y; Su JA; Tan YS
Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):110-4. PubMed ID: 21575478
[TBL] [Abstract][Full Text] [Related]
27. Splicing factor hnRNPA2B1 contributes to tumorigenic potential of breast cancer cells through STAT3 and ERK1/2 signaling pathway.
Hu Y; Sun Z; Deng J; Hu B; Yan W; Wei H; Jiang J
Tumour Biol; 2017 Mar; 39(3):1010428317694318. PubMed ID: 28351333
[TBL] [Abstract][Full Text] [Related]
28. Linc01232 promotes the metastasis of pancreatic cancer by suppressing the ubiquitin-mediated degradation of HNRNPA2B1 and activating the A-Raf-induced MAPK/ERK signaling pathway.
Meng LD; Shi GD; Ge WL; Huang XM; Chen Q; Yuan H; Wu PF; Lu YC; Shen P; Zhang YH; Cao SJ; Miao Y; Tu M; Jiang KR
Cancer Lett; 2020 Dec; 494():107-120. PubMed ID: 32814086
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Inflammation and Bone Erosion by RNA Interference-Mediated Silencing of Heterogeneous Nuclear RNP A2/B1 in Two Experimental Models of Rheumatoid Arthritis.
Herman S; Fischer A; Presumey J; Hoffmann M; Koenders MI; Escriou V; Apparailly F; Steiner G
Arthritis Rheumatol; 2015 Sep; 67(9):2536-46. PubMed ID: 26017221
[TBL] [Abstract][Full Text] [Related]
30. The discoidin domain receptor 1 gene has a functional A2RE sequence.
Roig B; Moyano S; Martorell L; Costas J; Vilella E
J Neurochem; 2012 Feb; 120(3):408-18. PubMed ID: 22077590
[TBL] [Abstract][Full Text] [Related]
31. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
32. Effect of hnRNPA2/B1 on the proliferation and apoptosis of glioma U251 cells via the regulation of AKT and STAT3 pathways.
Yin D; Kong C; Chen M
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32463472
[TBL] [Abstract][Full Text] [Related]
33. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression.
Tockman MS; Mulshine JL; Piantadosi S; Erozan YS; Gupta PK; Ruckdeschel JC; Taylor PR; Zhukov T; Zhou WH; Qiao YL; Yao SX
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2237-46. PubMed ID: 9815620
[TBL] [Abstract][Full Text] [Related]
34. Shutdown of achaete-scute homolog-1 expression by heterogeneous nuclear ribonucleoprotein (hnRNP)-A2/B1 in hypoxia.
Kasim M; Benko E; Winkelmann A; Mrowka R; Staudacher JJ; Persson PB; Scholz H; Meier JC; Fähling M
J Biol Chem; 2014 Sep; 289(39):26973-26988. PubMed ID: 25124043
[TBL] [Abstract][Full Text] [Related]
35. Gene trap mutagenesis of hnRNP A2/B1: a cryptic 3' splice site in the neomycin resistance gene allows continued expression of the disrupted cellular gene.
Roshon M; DeGregori JV; Ruley HE
BMC Genomics; 2003 Jan; 4(1):2. PubMed ID: 12546712
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of RND3/RhoE in glioblastoma patients promotes tumorigenesis through augmentation of notch transcriptional complex activity.
Liu B; Lin X; Yang X; Dong H; Yue X; Andrade KC; Guo Z; Yang J; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Chen Q; Mao S; Chen Q; Chang J
Cancer Med; 2015 Sep; 4(9):1404-16. PubMed ID: 26108681
[TBL] [Abstract][Full Text] [Related]
37. Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation.
He Y; Brown MA; Rothnagel JA; Saunders NA; Smith R
J Cell Sci; 2005 Jul; 118(Pt 14):3173-83. PubMed ID: 16014382
[TBL] [Abstract][Full Text] [Related]
38. CrkI adapter protein modulates cell migration and invasion in glioblastoma.
Takino T; Nakada M; Miyamori H; Yamashita J; Yamada KM; Sato H
Cancer Res; 2003 May; 63(9):2335-7. PubMed ID: 12727859
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers.
Sueoka E; Goto Y; Sueoka N; Kai Y; Kozu T; Fujiki H
Cancer Res; 1999 Apr; 59(7):1404-7. PubMed ID: 10197602
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-106b-5p boosts glioma tumorigensis by targeting multiple tumor suppressor genes.
Liu F; Gong J; Huang W; Wang Z; Wang M; Yang J; Wu C; Wu Z; Han B
Oncogene; 2014 Oct; 33(40):4813-22. PubMed ID: 24166509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]